Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested Capital

Gain Therapeutics (GANX) Return on Assets (2021 - 2025)

Gain Therapeutics (GANX) has 5 years of Return on Assets data on record, last reported at 1.86% in Q3 2025.

  • For Q3 2025, Return on Assets fell 57.0% year-over-year to 1.86%; the TTM value through Sep 2025 reached 1.86%, down 57.0%, while the annual FY2024 figure was 1.33%, 27.0% down from the prior year.
  • Return on Assets reached 1.86% in Q3 2025 per GANX's latest filing, down from 1.73% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.01% in Q4 2022 and bottomed at 1.86% in Q3 2025.
  • Average Return on Assets over 5 years is 0.74%, with a median of 0.28% recorded in 2022.
  • Peak YoY movement for Return on Assets: rose 14bps in 2022, then plummeted -137bps in 2023.
  • A 5-year view of Return on Assets shows it stood at 0.15% in 2021, then surged by 94bps to 0.01% in 2022, then plummeted by -14418bps to 1.38% in 2023, then fell by -12bps to 1.54% in 2024, then fell by -21bps to 1.86% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Assets were 1.86% in Q3 2025, 1.73% in Q2 2025, and 1.76% in Q1 2025.